EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Exscientia's enterprise value is $465.17 Mil.
Exscientia's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was $24.59 Mil. Therefore, Exscientia's EV-to-Revenue for today is 18.92.
The historical rank and industry rank for Exscientia's EV-to-Revenue or its related term are showing as below:
EXAI'
s EV-to-Revenue Range Over the Past 10 Years
Min: -4.31 Med: 12.83 Max: 69.2
Current: 16.55
During the past 5 years, the highest EV-to-Revenue of Exscientia was 69.20. The lowest was -4.31. And the median was 12.83.
EXAI's EV-to-Revenue is ranked worse than 64.93% of 1035
companies
in the Biotechnology industry
Industry Median: 8.1
vs EXAI: 16.55
As of today (2024-06-02), Exscientia's stock price is $5.28.
Exscientia's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $0.20. Therefore, Exscientia's PS Ratio for today is 26.80.
Exscientia EV-to-Revenue Historical Data
The historical data trend for Exscientia's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Exscientia's EV-to-Revenue
For the Biotechnology subindustry, Exscientia's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Exscientia's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Exscientia's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Exscientia's EV-to-Revenue falls into.
Exscientia's current Enterprise Value is $465.17 Mil.
Exscientia's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $24.59 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exscientia's share price for today is $5.28.
Exscientia's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.20.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Exscientia EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Exscientia's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EXAI has been successfully added to your 